首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3352篇
  免费   42篇
  国内免费   8篇
化学   2316篇
晶体学   18篇
力学   68篇
数学   545篇
物理学   455篇
  2021年   22篇
  2018年   39篇
  2017年   37篇
  2016年   36篇
  2015年   37篇
  2014年   42篇
  2013年   97篇
  2012年   94篇
  2011年   118篇
  2010年   85篇
  2009年   81篇
  2008年   111篇
  2007年   128篇
  2006年   108篇
  2005年   119篇
  2004年   116篇
  2003年   91篇
  2002年   95篇
  2001年   57篇
  2000年   79篇
  1999年   69篇
  1998年   53篇
  1997年   58篇
  1996年   50篇
  1995年   50篇
  1994年   41篇
  1993年   66篇
  1992年   55篇
  1991年   42篇
  1990年   30篇
  1989年   35篇
  1988年   41篇
  1987年   35篇
  1986年   53篇
  1985年   62篇
  1984年   43篇
  1983年   32篇
  1982年   40篇
  1981年   53篇
  1980年   40篇
  1979年   55篇
  1978年   44篇
  1977年   44篇
  1976年   38篇
  1975年   32篇
  1974年   38篇
  1973年   27篇
  1972年   27篇
  1971年   25篇
  1970年   25篇
排序方式: 共有3402条查询结果,搜索用时 15 毫秒
101.
102.
103.
Ester derivatives of N-phosphorylated 3(5)-methylpyrazole and 3-amino-1,2,4-triazole, respectively, have been synthesized. The results of hydrolysis studies are described.  相似文献   
104.
The applicability of pseudoscalar functions, in general, and of the Osipov–Pickup–Dunmur chirality index, in particular, as consistent chirality measures is discussed. It is shown that due to the presence of chiral zeros these functions are unsuited to measure the chirality of objects described by more than two independent parameters.  相似文献   
105.
Owing to heterogeneity in therapeutic response, efavirenz is of research and clinical interest. There is a need to quantitate it using noncostly and selective methods. A method for efavirenz quantitation in plasma containing HIV and tuberculosis drugs was developed. Chromatographic separation was carried out using a C18 column. The mobile phase consisted of 0.1% formic acid and acetonitrile, and was pumped at a flow rate of 0.3 mL/min. Efavirenz and ritonavir (internal standard) were monitored at 247 nm. Plasma proteins were precipitated by centrifugation. The analysis time was 6 min. The response was linear (r = 0.9997). The accuracy ranged between 98 and 115% (intraday) and between 99 and 117% (interday). The precision ranged from 1.670 to 4.087% (intraday) and from 3.447 to 13.347% (interday). Recovery ranged from 98 to 132%. Stability ranged between 99 and 123%. The selectivity was proven by analysis of drugs used for the management of HIV/AIDS and tuberculosis. Plasma sample analysis showed an efavirenz retention time of 5.57 min and a peak plasma concentration of 2.4 µg/mL occurring at 2 h. This method is rapid and selective, and thus suitable for monitoring efavirenz in patients with HIV/AIDS alone or co‐infected with tuberculosis in a less resourced setting. Copyright © 2013 John Wiley & Sons, Ltd.  相似文献   
106.
107.
108.
109.
110.
The monoacylphosphineoxide (MAPO) salts Na‐TPO and Li‐TPO and the bisacylphosphineoxide (BAPO) salts BAPO‐ONa and BAPO‐OLi define an important and in the latter case a new class of water‐soluble photoinitiators (PIs) for radical polymerization. These compounds showed excellent water‐solubility of at least 29 g/L for Na‐TPO and up to 60 g/L for BAPO‐ONa in deionized water, thus exceeding the solubility of the state of the art PI for water‐based systems Irgacure 2959 ( I2959 ) 6‐ to 12‐fold. However, biocompatibility, storage stability, and reactivity were equally important to replace the state of the art compounds. Concerning these properties, the MAPO and BAPO salts were at least in the same range (biocompatibility, stability) or showed even better results (reactivity) and had the additional advantage of visible light initiation. Na‐TPO and Li‐TPO achieved double bond conversions of an aqueous solution of N‐acryloylmorpholine over 97% with broad band irradiation (320–500 nm), Li‐TPO showed additionally very good biocompatibility (LC50 = 3.1 mmol/L) and BAPO‐OLi showed highest reactivity with visible light irradiation. © 2015 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2016 , 54, 473–479  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号